Healthcare firm Allergan has obtained approval from the US Food and Drug Administration (FDA) for its Natrelle Inspira round gel-filled smooth breast implants.
Allergan executive vice-president and research and development chief scientific officer Scott Whitcup said: "The FDA approval of Natrelle Inspira round gel-filled implants exemplifies our commitment to scientific innovation and to meeting the dynamic needs of plastic surgeons and their patients.
"In the past two years, Allergan has received FDA approval for three new and important breast implant options which represent the latest advancements in Allergan’s growing product portfolio."
The new breast implants are developed for breast augmentation of women with at least 22 years old. It includes primary breast augmentation to enhance breast size and revision surgery to correct or improve the result of a primary breast augmentation surgery.
The implants will also be used for breast reconstruction, which includes primary reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality.
Available with 243 size options and a variety of projection styles, the other line of Natrelle products includes 410 anatomically shaped implants, classic round gel implants and saline implants.